Necrolytic Migratory Erythema with Cryosurgery Intervention

Necrolytic migratory erythema (NME) is a rare skin condition, which is the first presenting manifestation in almost 70% of the patients with glucagonoma. It is characterized by well-defined scaly erythematous patches with crusted erosion in annular appearance. The predominant areas are genital area...

Full description

Bibliographic Details
Main Author: Kamolwan Pongparit
Format: Article
Language:English
Published: Mahidol University 2017-02-01
Series:Siriraj Medical Journal
Subjects:
Online Access:https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/77156
id doaj-8990dfec69504134a3852467f750e312
record_format Article
spelling doaj-8990dfec69504134a3852467f750e3122021-08-13T09:51:39ZengMahidol UniversitySiriraj Medical Journal2228-80822017-02-01691Necrolytic Migratory Erythema with Cryosurgery InterventionKamolwan Pongparit0Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700 Necrolytic migratory erythema (NME) is a rare skin condition, which is the first presenting manifestation in almost 70% of the patients with glucagonoma. It is characterized by well-defined scaly erythematous patches with crusted erosion in annular appearance. The predominant areas are genital area, intertrigenous sites and lower extremities. This article has presented the case who had a 5-month history of progressive erythematous scaling patches with crusted erosion on acral, trunk and intertriginous areas. He had been treated for several months at another hospital without definite diagnosis. Our investigations revealed diabetes mellitus and a 6.5x5.7x6.0 cm mass at pancreatic head without liver metastasis. Percutaneous biopsy revealed monomorphic round cells with pleomorphic nuclei which immunohistochemical staining which revealed strongly positive for neuroendocrine tumor. The diagnosis of probable glucagonoma associated with NME was established. Zinc supplement was initiated resulting in marked improvement of his rash. He went to Fuda Hospital in China to receive cryosurgery for his pancreatic tumor. Up until now, there has been no recurrence of his rash and his general condition remains stable for 3 years.  However, CT scan at 3 years after cryosurgery showed slight increase in size of pancreatic mass and increased degree of diffuse dilatation of main pancreatic duct and side-branch. Thus, long term follow-up is mandatory to conclude the outcome of cryosurgery for pancreatic cancer. https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/77156Cryosurgeryglucagonomanecrolytic migratory erythema
collection DOAJ
language English
format Article
sources DOAJ
author Kamolwan Pongparit
spellingShingle Kamolwan Pongparit
Necrolytic Migratory Erythema with Cryosurgery Intervention
Siriraj Medical Journal
Cryosurgery
glucagonoma
necrolytic migratory erythema
author_facet Kamolwan Pongparit
author_sort Kamolwan Pongparit
title Necrolytic Migratory Erythema with Cryosurgery Intervention
title_short Necrolytic Migratory Erythema with Cryosurgery Intervention
title_full Necrolytic Migratory Erythema with Cryosurgery Intervention
title_fullStr Necrolytic Migratory Erythema with Cryosurgery Intervention
title_full_unstemmed Necrolytic Migratory Erythema with Cryosurgery Intervention
title_sort necrolytic migratory erythema with cryosurgery intervention
publisher Mahidol University
series Siriraj Medical Journal
issn 2228-8082
publishDate 2017-02-01
description Necrolytic migratory erythema (NME) is a rare skin condition, which is the first presenting manifestation in almost 70% of the patients with glucagonoma. It is characterized by well-defined scaly erythematous patches with crusted erosion in annular appearance. The predominant areas are genital area, intertrigenous sites and lower extremities. This article has presented the case who had a 5-month history of progressive erythematous scaling patches with crusted erosion on acral, trunk and intertriginous areas. He had been treated for several months at another hospital without definite diagnosis. Our investigations revealed diabetes mellitus and a 6.5x5.7x6.0 cm mass at pancreatic head without liver metastasis. Percutaneous biopsy revealed monomorphic round cells with pleomorphic nuclei which immunohistochemical staining which revealed strongly positive for neuroendocrine tumor. The diagnosis of probable glucagonoma associated with NME was established. Zinc supplement was initiated resulting in marked improvement of his rash. He went to Fuda Hospital in China to receive cryosurgery for his pancreatic tumor. Up until now, there has been no recurrence of his rash and his general condition remains stable for 3 years.  However, CT scan at 3 years after cryosurgery showed slight increase in size of pancreatic mass and increased degree of diffuse dilatation of main pancreatic duct and side-branch. Thus, long term follow-up is mandatory to conclude the outcome of cryosurgery for pancreatic cancer.
topic Cryosurgery
glucagonoma
necrolytic migratory erythema
url https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/77156
work_keys_str_mv AT kamolwanpongparit necrolyticmigratoryerythemawithcryosurgeryintervention
_version_ 1721208764829270016